This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
The medical device sector is considered as one of the sunrise sectors in the country
The product is being launched in August 2023
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
The slogan for this year's World Blood Donor Day campaign is 'Give blood, give plasma, share life, share often'
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Subscribe To Our Newsletter & Stay Updated
